APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Hemostats

Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.

Selected research

Market Structure

Global Hemostats Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025199 pages

Choose your research edition.

Industry ResearchHemostats Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Hemostats Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Hemostats Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hemostats Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Hemostats Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.

Global Hemostats key players include Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard, The Medicines Company, etc. Global top five manufacturers hold a share over 55%.

North America is the largest market, with a share about 35%, followed by China, and Europe, both have a share over 35 percent.

Read the full market overview

In terms of product, Thrombin-Based Hemostats is the largest segment, with a share over 40%. And in terms of application, the largest application is Hospital Treatment, followed by Prehospital Treatment, etc.

This report provides an overview of the global Hemostats market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hemostats and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hemostats sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hemostats market size, projected growth trends, production technologies, key applications, and end-use industries.

Hemostats Segment by Company

Ethicon

Pfizer

Baxter International Inc.

C. R. Bard

The Medicines Company

Anika Therapeutics

Advanced Medical Solutions

Integra LifeSciences Corporation

B Braun Melsungen AG

Gelita Medical GmbH

Equimedical

Vascular Solutions

Marine Polymer Technologies

Z-Medica, LLC

CryoLife

BioCer Entwicklungs-GmbH.

Biom'Up SAS

Hemostats Segment by Type

Thrombin-Based Hemostats

Oxidized Regenerated Cellulose Based Hemostats

Combination Hemostats

Gelatin Based Hemostats

Collagen Based Hemostats

Hemostats Segment by Application

Prehospital Treatment

Hospital Treatment

Hemostats Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostats market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemostats and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostats.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hemostats market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hemostats manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hemostats in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hemostats in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hemostats Industry Trends Table 2. Hemostats Industry Drivers Table 3. Hemostats Industry Opportunities and Challenges Table 4. Hemostats Industry Restraints Table 5. Global Hemostats Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hemostats Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hemostats Sales by Manufacturers (K Pcs) & (2021-2026) Table 8. Global Hemostats Sales Market Share by Manufacturers Table 9. Global Hemostats Average Sales Price (USD/Pcs) of Manufacturers (2021-2026) Table 10. Global Hemostats Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hemostats Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hemostats Manufacturers, Product Type & Application Table 13. Global Hemostats Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hemostats by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Thrombin-Based Hemostats Table 17. Major Manufacturers of Oxidized Regenerated Cellulose Based Hemostats Table 18. Major Manufacturers of Combination Hemostats Table 19. Major Manufacturers of Gelatin Based Hemostats Table 20. Major Manufacturers of Collagen Based Hemostats Table 21. Global Hemostats Sales by Type 2021 VS 2025 VS 2032 (K Pcs) Table 22. Global Hemostats Sales by Type (2021-2026) & (K Pcs) Table 23. Global Hemostats Sales by Type (2027-2032) & (K Pcs) Table 24. Global Hemostats Sales Market Share by Type (2021-2026) Table 25. Global Hemostats Sales Market Share by Type (2027-2032) Table 26. Global Hemostats Revenue by Type 2021 VS 2025 VS 2032 (K Pcs) Table 27. Global Hemostats Revenue by Type (2021-2026) & (K Pcs) Table 28. Global Hemostats Revenue by Type (2027-2032) & (K Pcs) Table 29. Global Hemostats Revenue Market Share by Type (2021-2026) Table 30. Global Hemostats Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Prehospital Treatment Table 32. Major Manufacturers of Hospital Treatment Table 33. Global Hemostats Sales by Application 2021 VS 2025 VS 2032 (K Pcs) Table 34. Global Hemostats Sales by Application (2021-2026) & (K Pcs) Table 35. Global Hemostats Sales by Application (2027-2032) & (K Pcs) Table 36. Global Hemostats Sales Market Share by Application (2021-2026) Table 37. Global Hemostats Sales Market Share by Application (2027-2032) Table 38. Global Hemostats Revenue by Application 2021 VS 2025 VS 2032 (K Pcs) Table 39. Global Hemostats Revenue by Application (2021-2026) & (K Pcs) Table 40. Global Hemostats Revenue by Application (2027-2032) & (K Pcs) Table 41. Global Hemostats Revenue Market Share by Application (2021-2026) Table 42. Global Hemostats Revenue Market Share by Application (2027-2032) Table 43. Global Hemostats Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Table 44. Global Hemostats Sales by Region (2021-2026) & (K Pcs) Table 45. Global Hemostats Sales Market Share by Region (2021-2026) Table 46. Global Hemostats Sales Forecasted by Region (2027-2032) & (K Pcs) Table 47. Global Hemostats Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Hemostats Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 49. North America Hemostats Sales by Country (2021-2026) & (K Pcs) Table 50. North America Hemostats Sales by Country (2027-2032) & (K Pcs) Table 51. Europe Hemostats Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 52. Europe Hemostats Sales by Country (2021-2026) & (K Pcs) Table 53. Europe Hemostats Sales by Country (2027-2032) & (K Pcs) Table 54. Asia Pacific Hemostats Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 55. Asia Pacific Hemostats Sales by Country (2021-2026) & (K Pcs) Table 56. Asia Pacific Hemostats Sales by Country (2027-2032) & (K Pcs) Table 57. South America, Middle East and Africa Hemostats Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 58. South America, Middle East and Africa Hemostats Sales by Country (2021-2026) & (K Pcs) Table 59. South America, Middle East and Africa Hemostats Sales by Country (2027-2032) & (K Pcs) Table 60. Global Hemostats Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Hemostats Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Hemostats Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Hemostats Revenue Market Share by Region (2021-2026) Table 64. Global Hemostats Revenue Market Share by Region (2027-2032) Table 65. Ethicon Company Information Table 66. Ethicon Business Overview Table 67. Ethicon Hemostats Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Ethicon Hemostats Product Portfolio Table 69. Ethicon Recent Development Table 70. Pfizer Company Information Table 71. Pfizer Business Overview Table 72. Pfizer Hemostats Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Pfizer Hemostats Product Portfolio Table 74. Pfizer Recent Development Table 75. Baxter International Inc. Company Information Table 76. Baxter International Inc. Business Overview Table 77. Baxter International Inc. Hemostats Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Baxter International Inc. Hemostats Product Portfolio Table 79. Baxter International Inc. Recent Development Table 80. C. R. Bard Company Information Table 81. C. R. Bard Business Overview Table 82. C. R. Bard Hemostats Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. C. R. Bard Hemostats Product Portfolio Table 84. C. R. Bard Recent Development Table 85. The Medicines Company Company Information Table 86. The Medicines Company Business Overview Table 87. The Medicines Company Hemostats Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. The Medicines Company Hemostats Product Portfolio Table 89. The Medicines Company Recent Development Table 90. Anika Therapeutics Company Information Table 91. Anika Therapeutics Business Overview Table 92. Anika Therapeutics Hemostats Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Anika Therapeutics Hemostats Product Portfolio Table 94. Anika Therapeutics Recent Development Table 95. Advanced Medical Solutions Company Information Table 96. Advanced Medical Solutions Business Overview Table 97. Advanced Medical Solutions Hemostats Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Advanced Medical Solutions Hemostats Product Portfolio Table 99. Advanced Medical Solutions Recent Development Table 100. Integra LifeSciences Corporation Company Information Table 101. Integra LifeSciences Corporation Business Overview Table 102. Integra LifeSciences Corporation Hemostats Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Integra LifeSciences Corporation Hemostats Product Portfolio Table 104. Integra LifeSciences Corporation Recent Development Table 105. B Braun Melsungen AG Company Information Table 106. B Braun Melsungen AG Business Overview Table 107. B Braun Melsungen AG Hemostats Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. B Braun Melsungen AG Hemostats Product Portfolio Table 109. B Braun Melsungen AG Recent Development Table 110. Gelita Medical GmbH Company Information Table 111. Gelita Medical GmbH Business Overview Table 112. Gelita Medical GmbH Hemostats Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Gelita Medical GmbH Hemostats Product Portfolio Table 114. Gelita Medical GmbH Recent Development Table 115. Equimedical Company Information Table 116. Equimedical Business Overview Table 117. Equimedical Hemostats Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Equimedical Hemostats Product Portfolio Table 119. Equimedical Recent Development Table 120. Vascular Solutions Company Information Table 121. Vascular Solutions Business Overview Table 122. Vascular Solutions Hemostats Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Vascular Solutions Hemostats Product Portfolio Table 124. Vascular Solutions Recent Development Table 125. Marine Polymer Technologies Company Information Table 126. Marine Polymer Technologies Business Overview Table 127. Marine Polymer Technologies Hemostats Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Marine Polymer Technologies Hemostats Product Portfolio Table 129. Marine Polymer Technologies Recent Development Table 130. Z-Medica, LLC Company Information Table 131. Z-Medica, LLC Business Overview Table 132. Z-Medica, LLC Hemostats Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Z-Medica, LLC Hemostats Product Portfolio Table 134. Z-Medica, LLC Recent Development Table 135. CryoLife Company Information Table 136. CryoLife Business Overview Table 137. CryoLife Hemostats Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. CryoLife Hemostats Product Portfolio Table 139. CryoLife Recent Development Table 140. BioCer Entwicklungs-GmbH. Company Information Table 141. BioCer Entwicklungs-GmbH. Business Overview Table 142. BioCer Entwicklungs-GmbH. Hemostats Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. BioCer Entwicklungs-GmbH. Hemostats Product Portfolio Table 144. BioCer Entwicklungs-GmbH. Recent Development Table 145. Biom'Up SAS Company Information Table 146. Biom'Up SAS Business Overview Table 147. Biom'Up SAS Hemostats Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Biom'Up SAS Hemostats Product Portfolio Table 149. Biom'Up SAS Recent Development Table 150. Key Raw Materials Table 151. Raw Materials Key Suppliers Table 152. Hemostats Distributors List Table 153. Hemostats Customers List Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Hemostats Product Image Figure 2. Global Hemostats Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hemostats Market Size (2021-2032) & (US$ Million) Figure 4. Global Hemostats Sales (2021-2032) & (K Pcs) Figure 5. Global Hemostats Average Price (USD/Pcs) & (2021-2032) Figure 6. Global Top 5 and 10 Hemostats Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Thrombin-Based Hemostats Image Figure 9. Oxidized Regenerated Cellulose Based Hemostats Image Figure 10. Combination Hemostats Image Figure 11. Gelatin Based Hemostats Image Figure 12. Collagen Based Hemostats Image Figure 13. Global Hemostats Sales by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 14. Global Hemostats Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Hemostats Sales Market Share by Type (2021-2032) Figure 16. Global Hemostats Revenue by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 17. Global Hemostats Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Hemostats Revenue Market Share by Type (2021-2032) Figure 19. Prehospital Treatment Image Figure 20. Hospital Treatment Image Figure 21. Global Hemostats Sales by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 22. Global Hemostats Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Hemostats Sales Market Share by Application (2021-2032) Figure 24. Global Hemostats Revenue by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 25. Global Hemostats Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Hemostats Revenue Market Share by Application (2021-2032) Figure 27. North America Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 28. North America Hemostats Sales Market Share by Country (2021-2032) Figure 29. U.S. Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 30. Canada Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 31. Mexico Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 32. Europe Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 33. Europe Hemostats Sales Market Share by Country (2021-2032) Figure 34. Germany Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 35. France Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 36. U.K. Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 37. Italy Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 38. Netherlands Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 39. Asia Pacific Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 40. Asia Pacific Hemostats Sales Market Share by Country (2021-2032) Figure 41. China Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 42. Japan Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 43. South Korea Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 44. Southeast Asia Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 45. India Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 46. Australia Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 47. South America, Middle East and Africa Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 48. South America, Middle East and Africa Hemostats Sales Market Share by Country (2021-2032) Figure 49. Brazil Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 50. South Africa Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 51. Saudi Arabia Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 52. Turkey Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 53. Argentina Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 54. UAE Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 55. Egypt Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 56. Chile Hemostats Sales and Growth Rate (2021-2032) & (K Pcs) Figure 57. Global Hemostats Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Hemostats Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Hemostats Revenue (2021-2032) & (US$ Million) Figure 60. North America Hemostats Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Hemostats Revenue (2021-2032) & (US$ Million) Figure 62. Europe Hemostats Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Hemostats Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Hemostats Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Hemostats Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Hemostats Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Hemostats Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Hemostats Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Thrombin-Based Hemostats
  • Oxidized Regenerated Cellulose Based Hemostats
  • Combination Hemostats
  • Gelatin Based Hemostats
  • Collagen Based Hemostats
Applications
  • Prehospital Treatment
  • Hospital Treatment
Companies covered
  • Ethicon
  • Pfizer
  • Baxter International Inc.
  • C. R. Bard
  • The Medicines Company
  • Anika Therapeutics
  • Advanced Medical Solutions
  • Integra LifeSciences Corporation
  • B Braun Melsungen AG
  • Gelita Medical GmbH
  • Equimedical
  • Vascular Solutions
  • Marine Polymer Technologies
  • Z-Medica, LLC
  • CryoLife
  • BioCer Entwicklungs-GmbH.
  • Biom'Up SAS

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hemostats Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hemostats Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hemostats Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hemostats Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hemostats Market Dynamics
  1. 2.1 Hemostats Industry Trends
  2. 2.2 Hemostats Industry Drivers
  3. 2.3 Hemostats Industry Opportunities and Challenges
  4. 2.4 Hemostats Industry Restraints
3 Hemostats Market by Manufacturers
  1. 3.1 Global Hemostats Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hemostats Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hemostats Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hemostats Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hemostats Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hemostats Manufacturers, Product Type & Application
  7. 3.7 Global Hemostats Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hemostats Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hemostats Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hemostats Tier 1, Tier 2, and Tier 3
4 Hemostats Market by Type
  1. 4.1 Hemostats Type Introduction
  2. 4.1.1 Thrombin-Based Hemostats
  3. 4.1.2 Oxidized Regenerated Cellulose Based Hemostats
  4. 4.1.3 Combination Hemostats
  5. 4.1.4 Gelatin Based Hemostats
  6. 4.1.5 Collagen Based Hemostats
  7. 4.2 Global Hemostats Sales by Type
  8. 4.2.1 Global Hemostats Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Hemostats Sales by Type (2021-2032)
  10. 4.2.3 Global Hemostats Sales Market Share by Type (2021-2032)
  11. 4.3 Global Hemostats Revenue by Type
  12. 4.3.1 Global Hemostats Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Hemostats Revenue by Type (2021-2032)
  14. 4.3.3 Global Hemostats Revenue Market Share by Type (2021-2032)
5 Hemostats Market by Application
  1. 5.1 Hemostats Application Introduction
  2. 5.1.1 Prehospital Treatment
  3. 5.1.2 Hospital Treatment
  4. 5.2 Global Hemostats Sales by Application
  5. 5.2.1 Global Hemostats Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Hemostats Sales by Application (2021-2032)
  7. 5.2.3 Global Hemostats Sales Market Share by Application (2021-2032)
  8. 5.3 Global Hemostats Revenue by Application
  9. 5.3.1 Global Hemostats Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Hemostats Revenue by Application (2021-2032)
  11. 5.3.3 Global Hemostats Revenue Market Share by Application (2021-2032)
6 Global Hemostats Sales by Region
  1. 6.1 Global Hemostats Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hemostats Sales by Region (2021-2032)
  3. 6.2.1 Global Hemostats Sales by Region (2021-2026)
  4. 6.2.2 Global Hemostats Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hemostats Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hemostats Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hemostats Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hemostats Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hemostats Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hemostats Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hemostats Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hemostats Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hemostats Revenue by Region
  1. 7.1 Global Hemostats Revenue by Region
  2. 7.1.1 Global Hemostats Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hemostats Revenue by Region (2021-2026)
  4. 7.1.3 Global Hemostats Revenue by Region (2027-2032)
  5. 7.1.4 Global Hemostats Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hemostats Revenue (2021-2032)
  8. 7.2.2 North America Hemostats Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hemostats Revenue (2021-2032)
  11. 7.3.2 Europe Hemostats Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hemostats Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hemostats Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hemostats Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hemostats Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Ethicon
  2. 8.1.1 Ethicon Company Information
  3. 8.1.2 Ethicon Business Overview
  4. 8.1.3 Ethicon Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Ethicon Hemostats Product Portfolio
  6. 8.1.5 Ethicon Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Hemostats Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Baxter International Inc.
  14. 8.3.1 Baxter International Inc. Company Information
  15. 8.3.2 Baxter International Inc. Business Overview
  16. 8.3.3 Baxter International Inc. Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Baxter International Inc. Hemostats Product Portfolio
  18. 8.3.5 Baxter International Inc. Recent Developments
  19. 8.4 C. R. Bard
  20. 8.4.1 C. R. Bard Company Information
  21. 8.4.2 C. R. Bard Business Overview
  22. 8.4.3 C. R. Bard Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 C. R. Bard Hemostats Product Portfolio
  24. 8.4.5 C. R. Bard Recent Developments
  25. 8.5 The Medicines Company
  26. 8.5.1 The Medicines Company Company Information
  27. 8.5.2 The Medicines Company Business Overview
  28. 8.5.3 The Medicines Company Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 The Medicines Company Hemostats Product Portfolio
  30. 8.5.5 The Medicines Company Recent Developments
  31. 8.6 Anika Therapeutics
  32. 8.6.1 Anika Therapeutics Company Information
  33. 8.6.2 Anika Therapeutics Business Overview
  34. 8.6.3 Anika Therapeutics Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Anika Therapeutics Hemostats Product Portfolio
  36. 8.6.5 Anika Therapeutics Recent Developments
  37. 8.7 Advanced Medical Solutions
  38. 8.7.1 Advanced Medical Solutions Company Information
  39. 8.7.2 Advanced Medical Solutions Business Overview
  40. 8.7.3 Advanced Medical Solutions Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Advanced Medical Solutions Hemostats Product Portfolio
  42. 8.7.5 Advanced Medical Solutions Recent Developments
  43. 8.8 Integra LifeSciences Corporation
  44. 8.8.1 Integra LifeSciences Corporation Company Information
  45. 8.8.2 Integra LifeSciences Corporation Business Overview
  46. 8.8.3 Integra LifeSciences Corporation Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Integra LifeSciences Corporation Hemostats Product Portfolio
  48. 8.8.5 Integra LifeSciences Corporation Recent Developments
  49. 8.9 B Braun Melsungen AG
  50. 8.9.1 B Braun Melsungen AG Company Information
  51. 8.9.2 B Braun Melsungen AG Business Overview
  52. 8.9.3 B Braun Melsungen AG Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 B Braun Melsungen AG Hemostats Product Portfolio
  54. 8.9.5 B Braun Melsungen AG Recent Developments
  55. 8.10 Gelita Medical GmbH
  56. 8.10.1 Gelita Medical GmbH Company Information
  57. 8.10.2 Gelita Medical GmbH Business Overview
  58. 8.10.3 Gelita Medical GmbH Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Gelita Medical GmbH Hemostats Product Portfolio
  60. 8.10.5 Gelita Medical GmbH Recent Developments
  61. 8.11 Equimedical
  62. 8.11.1 Equimedical Company Information
  63. 8.11.2 Equimedical Business Overview
  64. 8.11.3 Equimedical Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Equimedical Hemostats Product Portfolio
  66. 8.11.5 Equimedical Recent Developments
  67. 8.12 Vascular Solutions
  68. 8.12.1 Vascular Solutions Company Information
  69. 8.12.2 Vascular Solutions Business Overview
  70. 8.12.3 Vascular Solutions Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Vascular Solutions Hemostats Product Portfolio
  72. 8.12.5 Vascular Solutions Recent Developments
  73. 8.13 Marine Polymer Technologies
  74. 8.13.1 Marine Polymer Technologies Company Information
  75. 8.13.2 Marine Polymer Technologies Business Overview
  76. 8.13.3 Marine Polymer Technologies Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Marine Polymer Technologies Hemostats Product Portfolio
  78. 8.13.5 Marine Polymer Technologies Recent Developments
  79. 8.14 Z-Medica, LLC
  80. 8.14.1 Z-Medica, LLC Company Information
  81. 8.14.2 Z-Medica, LLC Business Overview
  82. 8.14.3 Z-Medica, LLC Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Z-Medica, LLC Hemostats Product Portfolio
  84. 8.14.5 Z-Medica, LLC Recent Developments
  85. 8.15 CryoLife
  86. 8.15.1 CryoLife Company Information
  87. 8.15.2 CryoLife Business Overview
  88. 8.15.3 CryoLife Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 CryoLife Hemostats Product Portfolio
  90. 8.15.5 CryoLife Recent Developments
  91. 8.16 BioCer Entwicklungs-GmbH.
  92. 8.16.1 BioCer Entwicklungs-GmbH. Company Information
  93. 8.16.2 BioCer Entwicklungs-GmbH. Business Overview
  94. 8.16.3 BioCer Entwicklungs-GmbH. Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 BioCer Entwicklungs-GmbH. Hemostats Product Portfolio
  96. 8.16.5 BioCer Entwicklungs-GmbH. Recent Developments
  97. 8.17 Biom'Up SAS
  98. 8.17.1 Biom'Up SAS Company Information
  99. 8.17.2 Biom'Up SAS Business Overview
  100. 8.17.3 Biom'Up SAS Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Biom'Up SAS Hemostats Product Portfolio
  102. 8.17.5 Biom'Up SAS Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hemostats Value Chain Analysis
  2. 9.1.1 Hemostats Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hemostats Production Mode & Process
  6. 9.2 Hemostats Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hemostats Distributors
  9. 9.2.3 Hemostats Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst